JESSY PALATHINKAL: Open Payments
NPI 1851945935 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$90 in 4 payments from 4 companies in 2025. Trend: 2023 $1,076 · 2024 $748 · 2025 $90
Food & beverage: $90
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 1 | $28 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $27 |
| Lilly USA, LLC | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $14 |
Products named: TRELEGY ELLIPTA, CAPLYTA, MOUNJARO, GEMTESA.
Industry payments across PA — which companies pay providers there.
